Modified polynucleotides for the production of G-CSF
US8680069B2 · kind B2 · utility
148Cited by
175References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 18, 2013 |
| Grant date | Mar 25, 2014 |
| Priority date | — |
| Expiry date | May 18, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12P21/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure provides, inter alia, formulation compositions comprising modified nucleic acid molecules which may encode a protein, a protein precursor, or a partially or fully processed form of the protein or a protein precursor. The formulation composition may further include a modified nucleic acid molecule and a delivery agent. The present invention further provides nucleic acids useful for encoding polypeptides capable of modulating a cell's function and/or activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.